Cargando…
Kaposi’s Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma
Kaposi’s sarcoma-associated herpesvirus (KSHV) causes primary effusion lymphoma (PEL). The cellular transcription factor (TF) interferon (IFN) regulatory factor 4 (IRF4) is an essential oncogene in PEL, but its specific role in PEL and how KSHV deregulates IRF4 remain unknown. Here, we report that t...
Autores principales: | Manzano, Mark, Günther, Thomas, Ju, Hyunwoo, Nicholas, John, Bartom, Elizabeth T., Grundhoff, Adam, Gottwein, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448273/ https://www.ncbi.nlm.nih.gov/pubmed/32843547 http://dx.doi.org/10.1128/mBio.01457-20 |
Ejemplares similares
-
Kaposi’s Sarcoma-Associated Herpesvirus microRNAs
por: Gottwein, Eva
Publicado: (2012) -
The Oncogenic Kaposi’s Sarcoma-Associated Herpesvirus Encodes a Mimic of the Tumor-Suppressive miR-15/16 miRNA Family
por: Morrison, Kylee, et al.
Publicado: (2019) -
The Epigenetic Landscape of Latent Kaposi Sarcoma-Associated Herpesvirus Genomes
por: Günther, Thomas, et al.
Publicado: (2010) -
Epigenetic control in Kaposi sarcoma-associated herpesvirus infection and associated disease
por: Fröhlich, Jacqueline, et al.
Publicado: (2020) -
Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma
por: Burbelo, Peter D, et al.
Publicado: (2010)